| Wymer Physical Therapy | |
|
4455 S Padre Island Dr, Suite 8, Corpus Christi, TX 78411-5101 | |
| (361) 879-0920 | |
| (361) 879-0940 |
| Full Name | Wymer Physical Therapy |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 4455 S Padre Island Dr, Corpus Christi, Texas |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003931288 | NPI | - | NPPES |
| 28012 | Other | TX | BCBS BLUELINK # |
| B0028012 | Other | TX | BCBS UPIN# |
| 659504 | Other | TX | BCBS PROVIDER # |
| 10779438 | Other | TX | CAQH PROVIDER # |
| 1080186-02 | Medicaid | TX | |
| 200006701 | Other | TX | DEPARTMENT OF LABOR # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1030773 (Texas) | Primary |
| Provider Name | Peter H Schep |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255406419 PECOS PAC ID: 6608773387 Enrollment ID: I20031219000098 |
News Archive
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Blocking a newly identified "immune memory checkpoint" in immune cells could improve immunotherapy and help prevent cancers from recurring, according to new findings in mice and human samples by researchers at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.
University of Washington engineers and physicians have developed a smartphone application that checks for jaundice in newborns and can deliver results to parents and pediatricians within minutes. It could serve as a screening tool to determine whether a baby needs a blood test - the gold standard for detecting high levels of bilirubin.
An article in the Times Courier recently highlighted the Partnership for Prescription Assistance (PPA), a group that has helped more than 6 million uninsured and financially struggling patients find assistance programs that provide the medicines they need for free or nearly free.
› Verified 5 days ago
| Provider Name | Richard D Wymer |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1831261106 PECOS PAC ID: 7113956681 Enrollment ID: I20050805000315 |
News Archive
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Blocking a newly identified "immune memory checkpoint" in immune cells could improve immunotherapy and help prevent cancers from recurring, according to new findings in mice and human samples by researchers at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.
University of Washington engineers and physicians have developed a smartphone application that checks for jaundice in newborns and can deliver results to parents and pediatricians within minutes. It could serve as a screening tool to determine whether a baby needs a blood test - the gold standard for detecting high levels of bilirubin.
An article in the Times Courier recently highlighted the Partnership for Prescription Assistance (PPA), a group that has helped more than 6 million uninsured and financially struggling patients find assistance programs that provide the medicines they need for free or nearly free.
› Verified 5 days ago
| Provider Name | Stephen M Hopkins |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1942431861 PECOS PAC ID: 0749504967 Enrollment ID: I20150116002145 |
News Archive
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Blocking a newly identified "immune memory checkpoint" in immune cells could improve immunotherapy and help prevent cancers from recurring, according to new findings in mice and human samples by researchers at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.
University of Washington engineers and physicians have developed a smartphone application that checks for jaundice in newborns and can deliver results to parents and pediatricians within minutes. It could serve as a screening tool to determine whether a baby needs a blood test - the gold standard for detecting high levels of bilirubin.
An article in the Times Courier recently highlighted the Partnership for Prescription Assistance (PPA), a group that has helped more than 6 million uninsured and financially struggling patients find assistance programs that provide the medicines they need for free or nearly free.
› Verified 5 days ago
| Provider Name | Lauren Jaekle |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1912508227 PECOS PAC ID: 0547670952 Enrollment ID: I20201112002792 |
News Archive
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Blocking a newly identified "immune memory checkpoint" in immune cells could improve immunotherapy and help prevent cancers from recurring, according to new findings in mice and human samples by researchers at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.
University of Washington engineers and physicians have developed a smartphone application that checks for jaundice in newborns and can deliver results to parents and pediatricians within minutes. It could serve as a screening tool to determine whether a baby needs a blood test - the gold standard for detecting high levels of bilirubin.
An article in the Times Courier recently highlighted the Partnership for Prescription Assistance (PPA), a group that has helped more than 6 million uninsured and financially struggling patients find assistance programs that provide the medicines they need for free or nearly free.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wymer Physical Therapy 4455 S Padre Island Dr, Suite 8, Corpus Christi, TX 78411-5101 Ph: (361) 879-0920 | Wymer Physical Therapy 4455 S Padre Island Dr, Suite 8, Corpus Christi, TX 78411-5101 Ph: (361) 879-0920 |
News Archive
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Blocking a newly identified "immune memory checkpoint" in immune cells could improve immunotherapy and help prevent cancers from recurring, according to new findings in mice and human samples by researchers at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.
University of Washington engineers and physicians have developed a smartphone application that checks for jaundice in newborns and can deliver results to parents and pediatricians within minutes. It could serve as a screening tool to determine whether a baby needs a blood test - the gold standard for detecting high levels of bilirubin.
An article in the Times Courier recently highlighted the Partnership for Prescription Assistance (PPA), a group that has helped more than 6 million uninsured and financially struggling patients find assistance programs that provide the medicines they need for free or nearly free.
› Verified 5 days ago
Premier Physical Therapy, Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3633 S Staples St, Corpus Christi, TX 78411 Phone: 361-225-2525 Fax: 361-225-2530 | |
Brian M Solecki, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4300 S Padre Island Dr, Suite 1-1, Corpus Christi, TX 78411 Phone: 361-993-6011 Fax: 361-993-7939 | |
Dylan Cooke, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5026 Deepwood Cir, Corpus Christi, TX 78415 Phone: 361-854-2278 Fax: 361-854-2389 | |
Gabrielle Nicole Rhyne, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 5440 Everhart Rd Ste 1, Corpus Christi, TX 78411 Phone: 361-994-5224 | |
Traci Mccloskey, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 14302 Nemo Court, Corpus Christi, TX 78418 Phone: 361-949-9898 Fax: 361-949-9897 | |
Mrs. Carlos Emmanuel Dela Paz Zaens, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 601 Texan Trail, Suite 101, Corpus Christi, TX 78411 Phone: 361-814-7100 |